Attached files

file filename
EX-10.1 - AGREEMENT - Right On Brands, Inc.hltk_ex101.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-K

 

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported): July 17, 2017

 

HealthTalk Live, Inc.

(Exact name of small business issuer as specified in its charter)

 

Nevada

 

45-1994478

(State or other jurisdiction of incorporation or organization)

 

(IRS Employer Identification No.)

 

11749 W. Pico Blvd., Los Angeles, CA 90064

(Address of principal executive offices)

 

(424) 259-3521

(Issuer’s telephone number)

 

______________________________________________

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 
 
 

SECTION 1 – REGISTRANT’S BUSINESS AND OPERATIONS

 

Item 1.01 Entry into a Material Definitive Agreement.

 

On July 17, 2017, we executed a Broker/ Company Agreement (the “Agreement”) with Sunshine Specialties (“Sunshine”). Under the Agreement, Sunshine will serve as the exclusive sales representative of our products in the Southern California area in exchange for a five percent (5%) sales commission, with a minimum commission of $1,500 per month. The initial term of the Agreement is one (1) year, subject to annual renewal. The Agreement, which is filed herewith as Exhibit 10.1, contains various additional terms and provisions which should be reviewed in their entirety.

 

SECTION 9 – Financial Statements and Exhibits

 

Item 9.01 Financial Statements and Exhibits.

 

Exhibit No.

 

Description

 

 

 

10.1

 

Broker / Company Agreement with Sunshine Specialties

 

 
2
 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.  

 

  HealthTalk Live, Inc.
       
Date: July 17, 2017 By: /s/ Daniel Crawford

 

 

Daniel Crawford  
    Chief Executive Officer  

 

 

3